Literature DB >> 7649401

Protein Motifs. 7. The four-helix bundle: what determines a fold?

S Kamtekar1, M H Hecht.   

Abstract

The four-helix bundle motif occurs in many structural contexts and in proteins that are functionally diverse. The motif can be classified into individual folds on the basis of topological and geometric properties. It has been thoroughly investigated structurally by both nuclear magnetic resonance and x-ray crystallography. Many mutants of four-helix bundles have been generated, and the motif has also been the target of de novo design studies. Taken together, these studies provide an opportunity to examine many of the forces governing protein folding. In this article we consider the relative importance of the burial of hydrophobic residues, loss of conformational entropy, packing interactions, interhelical turn composition, and helical dipole interactions all within the context of a single folding motif. We conclude by examining why de novo designed four-helix bundle proteins possess flexible interiors, and possible mechanisms by which natural proteins may lock their cores into rigid structures.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7649401     DOI: 10.1096/fasebj.9.11.7649401

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  35 in total

1.  Structural basis for the conformational adaptability of apolipophorin III, a helix-bundle exchangeable apolipoprotein.

Authors:  Jianjun Wang; Brian D Sykes; Robert O Ryan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

2.  NMR structure of the KaiC-interacting C-terminal domain of KaiA, a circadian clock protein: implications for KaiA-KaiC interaction.

Authors:  Ioannis Vakonakis; Jingchuan Sun; Tianfu Wu; Andreas Holzenburg; Susan S Golden; Andy C LiWang
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-28       Impact factor: 11.205

3.  Structure of the C-terminal domain of the clock protein KaiA in complex with a KaiC-derived peptide: implications for KaiC regulation.

Authors:  Ioannis Vakonakis; Andy C LiWang
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-15       Impact factor: 11.205

4.  Solution structure of the Set2-Rpb1 interacting domain of human Set2 and its interaction with the hyperphosphorylated C-terminal domain of Rpb1.

Authors:  Ming Li; Hemali P Phatnani; Ziqiang Guan; Harvey Sage; Arno L Greenleaf; Pei Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-28       Impact factor: 11.205

5.  Probing the cytochrome c' folding landscape.

Authors:  Ekaterina V Pletneva; Ziqing Zhao; Tetsunari Kimura; Krastina V Petrova; Harry B Gray; Jay R Winkler
Journal:  J Inorg Biochem       Date:  2007-06-21       Impact factor: 4.155

6.  The phi29 DNA polymerase:protein-primer structure suggests a model for the initiation to elongation transition.

Authors:  Satwik Kamtekar; Andrea J Berman; Jimin Wang; José M Lázaro; Miguel de Vega; Luis Blanco; Margarita Salas; Thomas A Steitz
Journal:  EMBO J       Date:  2006-03-02       Impact factor: 11.598

7.  Artificial Diiron Enzymes with a De Novo Designed Four-Helix Bundle Structure.

Authors:  Marco Chino; Ornella Maglio; Flavia Nastri; Vincenzo Pavone; William F DeGrado; Angela Lombardi
Journal:  Eur J Inorg Chem       Date:  2015-07-06       Impact factor: 2.524

8.  Apolipoprotein A-V N-terminal domain lipid interaction properties in vitro explain the hypertriglyceridemic phenotype associated with natural truncation mutants.

Authors:  Kasuen Wong-Mauldin; Vincent Raussens; Trudy M Forte; Robert O Ryan
Journal:  J Biol Chem       Date:  2009-10-13       Impact factor: 5.157

9.  Active barnase variants with completely random hydrophobic cores.

Authors:  D D Axe; N W Foster; A R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

10.  Assisted peptide folding by surface pattern recognition.

Authors:  Zhuoyun Zhuang; Andrew I Jewett; Silvan Kuttimalai; Giovanni Bellesia; S Gnanakaran; Joan-Emma Shea
Journal:  Biophys J       Date:  2011-03-02       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.